Showing results (2101-2110 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|November 19, 2013
Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in AustraliaIzyan A Wahab, Nicole L Pratt, Lisa M Kalisch, et al.
Drug Safety|August 25, 2014
Text mining for adverse drug events: the promise, challenges, and state of the artRave Harpaz, Alison Callahan, Suzanne Tamang, et al.
Drug Safety|December 17, 2013
Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysisUrsula Reichenpfader, Gerald Gartlehner, Laura C Morgan, et al.
Drug Safety|July 29, 2015
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six CountriesElizabeth E Roughead, Esther W Chan, Nam-Kyong Choi, et al.
Drug Safety|December 28, 2014
Safety considerations with pharmacological treatment of gestational diabetes mellitusDavid Simmons
Drug Safety|March 9, 2016
Good Signal Detection Practices: Evidence from IMI PROTECTAntoni F Z Wisniewski, Andrew Bate, Cedric Bousquet, et al.
Drug Safety|February 11, 2016
An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT IntervalTal Lorberbaum, Kevin J Sampson, Raymond L Woosley, et al.
Drug Safety|July 23, 2017
The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort StudyMeital Shlomo, Rafael Gorodischer, Sharon Daniel, et al.
Drug Safety|August 26, 2017
Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer's Capture of Spontaneous Reports for Exposed PregnanciesSteven T Bird, Kate Gelperin, Lockwood Taylor, et al.
Drug Safety|August 3, 2017
A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care PatientsAndrew M Tomlin, David M Reith, David J Woods, et al.
Pageof 311